Register to view the archived recording here.
Rosetta Genomics Says ‘Technical Obstacles’ Will Delay Colorectal Cancer Screen Launch
Rosetta also said that CEO Amir Avniel intends to step down in order to take the reins of Rosetta’s roughly year-old plant biotechnology unit, Rosetta Green. The disclosures were made as the company reported its second-quarter financial results.
New to GenomeWeb? Register here quickly.